METASTASES TO ABDOMINAL CAVITY

This adverse event was reported 492 times

These drugs are most commonly taken by patients reporting METASTASES TO ABDOMINAL CAVITY:

# Drug Count
0 CARBOPLATIN 40
1 BEVACIZUMAB 38
2 EVEROLIMUS 37
3 OCTREOTIDE ACETATE 35
4 CAPECITABINE 34
5 PACLITAXEL 27
6 DOCETAXEL 23
7 DOCETAXEL ANHYDROUS 23
8 LETROZOLE 22
9 METOCLOPRAMIDE HYDROCHLORIDE 22
See all common drugs associated with METASTASES TO ABDOMINAL CAVITY

METASTASES TO ABDOMINAL CAVITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PASSIFLORA INCARNATA, IGNATIA AMARA, VALERIANA OFFICINALIS 1 0.0833
1 DEMECLOCYCLINE 1 0.0044
2 NITROFURANTOIN (MACROCRYSTALS) 1 0.0016
3 ADEFOVIR DIPIVOXIL 2 0.0016
4 LANREOTIDE ACETATE 12 0.0015
5 CABAZITAXEL 5 0.0014
6 I. V. FAT EMULSION 1 0.0014
7 NERATINIB 3 0.0013
8 REGORAFENIB 14 0.0012
9 OCTREOTIDE ACETATE 35 0.0011
See all drugs enriched for association with METASTASES TO ABDOMINAL CAVITY